Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 23.1 Consent of Mayer Hoffman Mccann P.C., Independent Registered Public Accounting Firm
- 23.2 Consent of Grassi & Co., Cpas, P.C., Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- 97.1 Clawback Policy
- Download Excel data file
- View Excel data file
UNCY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-8 (Nos. 333-259476, 333-275965) and Form S-3 (Nos. 333-266890, 333-273221) of our report dated March 30, 2023, with respect to the financial statements of Unicycive Therapeutics, Inc. as of and for the year ended December 31, 2022, included in this Annual Report on Form 10-K for the year ended December 31, 2023.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
March 28, 2024